chr5-112819347-A-C
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PP3PM2_SupportingPS1PS4_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_000038.6(APC):c.1312+3A>C variant in APC is an intronic variant, which is located at the 3rd nucleotide in intron 10. This variant has been reported in 2 probands meeting phenotypic criteria, resulting in a total phenotype score of 2 points (PS4_Moderate, Ambry Genetics internal data, Tsukanov et al 2017; Russian Journal of Genetics, 2017, Vol. 53, No. 3, pp. 369–375). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The results from two in silico splicing predictors (SpliceAI and MaxEntScan) indicate that this variant may affect splicing by disrupting the donor splice site of intron 10 of APC (PP3). Moreover, this variant has similar in silico predictions compared to another noncanonical splicing variant at that same nucleotide position (c.1312+3A>G) (ClinVar ID: 217924), which is classified as pathogenic for FAP by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP (HCCP VCEP) (PS1). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal-dominant inherited FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: criteria PS1, PM2_Supporting, PP3, and PS4_Moderate applied (VCEP specifications version v2.1.0; date of approval 11/24/2023). LINK:https://erepo.genome.network/evrepo/ui/classification/CA658655920/MONDO:0021056/089
Frequency
Consequence
NM_000038.6 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- classic or attenuated familial adenomatous polyposisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- desmoid tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- familial adenomatous polyposis 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- gastric adenocarcinoma and proximal polyposis of the stomachInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- APC-related attenuated familial adenomatous polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Turcot syndrome with polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cenani-Lenz syndactyly syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:1
The NM_000038.6(APC):c.1312+3A>C variant in APC is an intronic variant, which is located at the 3rd nucleotide in intron 10. This variant has been reported in 2 probands meeting phenotypic criteria, resulting in a total phenotype score of 2 points (PS4_Moderate, Ambry Genetics internal data, Tsukanov et al 2017; Russian Journal of Genetics, 2017, Vol. 53, No. 3, pp. 369–375). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The results from two in silico splicing predictors (SpliceAI and MaxEntScan) indicate that this variant may affect splicing by disrupting the donor splice site of intron 10 of APC (PP3). Moreover, this variant has similar in silico predictions compared to another noncanonical splicing variant at that same nucleotide position (c.1312+3A>G) (ClinVar ID: 217924), which is classified as pathogenic for FAP by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP (HCCP VCEP) (PS1). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal-dominant inherited FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: criteria PS1, PM2_Supporting, PP3, and PS4_Moderate applied (VCEP specifications version v2.1.0; date of approval 11/24/2023). -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1312+3A>C intronic pathogenic mutation results from an A to C substitution 3 nucleotides after coding exon 9 in the APC gene. This alteration has been detected in an individual diagnosed with >100 adenomatous polyps (Tsukanov AS et al. Russian J of Genet. 2017;53(3):369-375). Another alteration impacting the same donor site (c.1312+3A>G) has been detected in numerous familial adenomatous polyposis (FAP) families (Aretz S, et al. Hum. Mutat. 2004 Nov; 24(5):370-80; Lagarde A, et al. J. Med. Genet. 2010 Oct; 47(10):721-2; Nielsen M, et al. Clin. Genet. 2007 May; 71(5):427-33; Filipe B, et al. Clin. Genet. 2009 Sep; 76(3):242-55; Ambry internal data) and RNA analysis has shown that the c.1312+3A>G alteration leads to exon 9 skipping (Ambry internal data; Aretz S et al. Hum Mutat. 2004 Nov;24(5):370-80). This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at